Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour

被引:0
|
作者
Osugo, Martin [1 ,2 ,3 ]
Wall, Matthew B. [4 ,5 ]
Selvaggi, Pierluigi [6 ,7 ]
Zahid, Uzma [1 ,8 ]
Finelli, Valeria [1 ]
Chapman, George E. [1 ,2 ,9 ,10 ]
Whitehurst, Thomas [2 ,11 ]
Onwordi, Ellis Chika [1 ,2 ,11 ,12 ]
Statton, Ben [2 ,5 ]
Mccutcheon, Robert A. [1 ,2 ,13 ,14 ]
Murray, Robin M. [1 ]
Marques, Tiago Reis [1 ,2 ]
Mehta, Mitul A. [6 ]
Howes, Oliver D. [1 ,2 ,3 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England
[2] Imperial Coll London, MRC Lab Med Sci, London, England
[3] South London & Maudsley NHS Fdn Trust, London, England
[4] Perceptive, London, England
[5] Imperial Coll London, Fac Med, London, England
[6] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England
[7] Univ Bari Aldo Moro, Dept Translat Biomed & Neurosci, Bari, Italy
[8] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England
[9] UCL, Fac Brain Sci, Div Psychiat, London, England
[10] North London NHS Fdn Trust, London, England
[11] East London NHS Fdn Trust, London, England
[12] Queen Mary Univ London, Wolfson Inst Populat Hlth, Ctr Psychiat & Mental Hlth, London, England
[13] Univ Oxford, Dept Psychiat, Oxford, England
[14] Oxford Hlth NHS Fdn Trust, Oxford, England
基金
英国医学研究理事会; 欧盟地平线“2020”; 英国惠康基金;
关键词
NEGATIVE SYMPTOM SCALE; SCHIZOPHRENIA; ARIPIPRAZOLE; ANTICIPATION; ACTIVATION; PREDICTION; BIFEPRUNOX; MOTIVATION; GLUTAMATE; OUTCOMES;
D O I
10.1038/s41467-025-56663-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Signalling at dopamine D2/D3 receptors is thought to underlie motivated behaviour, pleasure experiences and emotional expression based on animal studies, but it is unclear if this is the case in humans or how this relates to neural processing of reward stimuli. Using a randomised, double-blind, placebo-controlled, crossover neuroimaging study, we show in healthy humans that sustained dopamine D2/D3 receptor antagonism for 7 days results in negative symptoms (impairments in motivated behaviour, hedonic experience, verbal and emotional expression) and that this is related to blunted striatal response to reward stimuli. In contrast, 7 days of partial D2/D3 agonism does not disrupt reward signalling, motivated behaviour or hedonic experience. Both D2/D3 antagonism and partial agonism induce motor impairments, which are not related to striatal reward response. These findings identify a central role for D2/D3 signalling and reward processing in the mechanism underlying motivated behaviour and emotional responses in humans, with implications for understanding neuropsychiatric disorders such as schizophrenia and Parkinson's disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain
    N D Volkow
    G-J Wang
    J Logan
    D Alexoff
    J S Fowler
    P K Thanos
    C Wong
    V Casado
    S Ferre
    D Tomasi
    Translational Psychiatry, 2015, 5 : e549 - e549
  • [2] Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain
    Volkow, N. D.
    Wang, G-J
    Logan, J.
    Alexoff, D.
    Fowler, J. S.
    Thanos, P. K.
    Wong, C.
    Casado, V.
    Ferre, S.
    Tomasi, D.
    TRANSLATIONAL PSYCHIATRY, 2015, 5 : e549 - e549
  • [3] Striatal dopamine D2/D3 receptor availability in male smokers
    Yang, YK
    Yao, WJ
    McEvoy, JP
    Chu, CL
    Lee, IH
    Chen, PS
    Yeh, TL
    Chiu, NT
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2006, 146 (01) : 87 - 90
  • [4] Association of genetic ancestry with striatal dopamine D2/D3 receptor availability
    Wiers, C. E.
    Towb, P. C.
    Hodgkinson, C. A.
    Shen, P-H
    Freeman, C.
    Miller, G.
    Lindgren, E.
    Shokri-Kojori, E.
    Demiral, S. B.
    Kim, S. W.
    Tomasi, D.
    Sun, H.
    Wang, G-J
    Goldman, D.
    Volkow, N. D.
    MOLECULAR PSYCHIATRY, 2018, 23 (08) : 1711 - 1716
  • [5] Association of genetic ancestry with striatal dopamine D2/D3 receptor availability
    C E Wiers
    P C Towb
    C A Hodgkinson
    P-H Shen
    C Freeman
    G Miller
    E Lindgren
    E Shokri-Kojori
    Ş B Demiral
    S W Kim
    D Tomasi
    H Sun
    G-J Wang
    D Goldman
    N D Volkow
    Molecular Psychiatry, 2018, 23 : 1711 - 1716
  • [6] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Paul W. Czoty
    H. Donald Gage
    Pradeep K. Garg
    Sudha Garg
    Michael A. Nader
    Psychopharmacology, 2014, 231 : 613 - 619
  • [7] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Czoty, Paul W.
    Gage, H. Donald
    Garg, Pradeep K.
    Garg, Sudha
    Nader, Michael A.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 613 - 619
  • [8] Regulation of dopamine D2 and D3 receptor trafficking by arrestins and GRKs
    Kolobova, EA
    Gurevich, E
    Gurevich, V
    FASEB JOURNAL, 2004, 18 (08): : C161 - C161
  • [9] Striatal Dopamine D2/D3 Receptor Availability Varies Across Smoking Status
    Wiers, Corinde E.
    Cabrera, Elizabeth A.
    Tomasi, Dardo
    Wong, Christopher T.
    Demiral, Sukrui B.
    Kim, Sung Won
    Wang, Gene-Jack
    Volkow, Nora D.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (12) : 2325 - 2332
  • [10] Striatal Dopamine D2/D3 Receptor Availability Varies Across Smoking Status
    Corinde E Wiers
    Elizabeth A Cabrera
    Dardo Tomasi
    Christopher T Wong
    Şükrü B Demiral
    Sung Won Kim
    Gene-Jack Wang
    Nora D Volkow
    Neuropsychopharmacology, 2017, 42 : 2325 - 2332